A new class of experimental drug-like small molecules is showing great promise in targeting a brain enzyme to prevent early memory loss in Alzheimer’s disease.
Northwestern Medicine® scientists have found the molecular pathway that can prevent the death of immature ovarian eggs due to chemotherapy, potentially preserving fertility and endocrine function.
In a surprising new finding, a Northwestern Medicine® study has found a common molecular vulnerability in autism and fetal alcohol spectrum disorder. Both disorders have symptoms of social impairment and originate during brain development in utero.
Research published in The Journal of Neuroscience identifies a new key factor in the generation of febrile seizures, leading to a new therapeutic target for humans.
A phase 1 clinical trial for the first treatment to reset the immune system of multiple sclerosis patients showed that the therapy was safe and dramatically reduced patients’ immune systems’ reactivity to myelin by 50 to 75 percent, according to new Northwestern Medicine® research.
Northwestern University has established a major new initiative – the Developmental Therapeutics Institute – with an initial $10 million investment that will bring more early-stage clinical studies of new anti-cancer approaches to Chicago. This program will also develop much needed new therapies for cancer and other diseases based on Northwestern’s preclinical and translational research by…
The dangerously high salt levels in processed food and fast food remain essentially unchanged, notwithstanding numerous calls from public and private health agencies for the food industry to voluntarily reduce sodium levels, reports a new Northwestern Medicine® study conducted with the Center for Science in the Public Interest.
In a new preclinical study, a Northwestern Medicine® scientist has isolated the motor neurons in the brain that die in ALS and, for the first time, dressed them in a green fluorescent jacket. As a result, scientists will now be able to track what goes wrong in these cells to cause their deaths and be…
Within the next few decades, getting a new kidney could be as simple as having a doctor order an engineered organ that will be developed in the laboratory with a patient’s own cells. Delivery could take a few months and, theoretically, a patient might not need immunosuppressant drugs because his body would recognize the kidney…
A Northwestern Medicine® study has found Chicago’s Neighbor Carts pilot program last year was profitable for the vendors selling fresh produce and a boon for customers buying fruit, vegetables, and nuts. It was so successful, in fact, that this year the program will expand from eight to 30 carts, with new ones rolling out this…